drugset / Trial / NCT02645591

Randomized AmnioFix Study During Radical Prostatectomy

NCT02645591 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

The goal of this clinical research study is to learn about the safety and the effectiveness of using AmnioFix® (dehydrated human amnion/chorion membrane, also called dHACM) to help improve the return of erectile function and bladder control in patients after robotic assisted laparoscopic radical prostatectomy (RARP). dHACM is a section of tissue made from part of the placenta donated by a mother during a C-section. It looks like a small piece of tissue paper and is wrapped around the nerve bundles in the surgical area. The tissue may help the body's normal healing process.

Timeline

Start
2016-11
Primary completion
2019-11
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Dehydrated human amnion/chorion membrane Unknown — Other

Indications